Wednesday , April 22 2026
Home / Media OutReach (page 714)

Media OutReach

Pecan Energies, operator of Deepwater Tano/Cape Three Points (DWT/CTP) block, completes rebranding, committing to unlock prosperity for Ghana and beyond

ACCRA, GHANA – EQS Newswire – 4 March 2024 – Pecan Energies (www.PecanEnergies.com), the operator of the Deepwater Tano/Cape Three Points (DWT/CTP) block offshore Ghana is thrilled to announce the successful completion of its rebranding journey. The company has evolved with a new name, logo, and a revitalized brand identity …

Read More »

Focused on positive impact: Ricola becomes a B Corporation

LAUFEN, SWITZERLAND – Newsaktuell – 4 March 2024 – Marking an important milestone on its sustainability journey, Ricola is now a certified B Corporation™. This step reflects Ricola’s long-standing commitment to environmental stewardship and social responsibility, in line with its values as a family-owned enterprise. As B Corporation, Ricola has …

Read More »

Berlin Cures’ BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial

Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients in randomized placebo-controlled Phase-II-trial now recruited; no issues regarding safety observed. Berlin Cures innovative platform develops novel aptamer-based drugs to neutralize pathogenic functional autoantibodies, targeting …

Read More »

Heng An Standard Life (Asia) fully supports Hong Kong new Capital Investment Entrant Scheme with ILAS now available for application

HONG KONG SAR – Media OutReach Newswire – 4 March 2024 – Heng An Standard Life (Asia) Limited (“HASL Asia” or “the Company”) welcomes and fully supports Hong Kong new Capital Investment Entrant Scheme (CIES). The company is committed to tying in with government policies to improve Hong Kong’s competitive …

Read More »

Berlin Cures’ BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment

Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients in randomized placebo-controlled Phase-II-trial now recruited; no issues regarding safety observed. Berlin Cures innovative platform develops novel aptamer-based drugs to neutralize pathogenic functional autoantibodies, targeting …

Read More »

Kaohsiung Draws Potential Investors at Kumamoto Expo

KAOHSIUNG, TAIWAN – Media OutReach Newswire – 4 March 2024 – Headed by Deputy Mayor Lo Ta-sheng, the Kaohsiung delegation to KUMAMOTO Industrial Revitalization EXPO 2024 and for a fact-finding tour of Kyushu has wound up a hugely rewarding journey. Over the course of the two-day expo, the Kaohsiung Pavilion …

Read More »